Remi M Palmantier

Title: Remi M Palmantier: Innovator in Antigen Binding Proteins

Introduction

Remi M Palmantier is a notable inventor based in Laval, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. Her work has implications for therapeutic applications, especially in cancer treatment.

Latest Patents

Remi holds a patent for MAGE antigen binding proteins. This patent includes antigen binding proteins, such as antibodies, that bind to human MAGE-A3, along with polynucleotides encoding such proteins and their uses and manufacture. This innovation represents a crucial advancement in targeted therapies.

Career Highlights

Remi is currently employed at GlaxoSmithKline Biologicals SA, where she continues to push the boundaries of scientific research and development. Her expertise in the field has positioned her as a key player in the biotechnology sector.

Collaborations

Throughout her career, Remi has collaborated with esteemed colleagues, including Alain Bergeron and Normand Blais. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Remi M Palmantier's contributions to the field of antigen binding proteins exemplify her dedication to advancing biotechnology. Her work not only showcases her inventive spirit but also highlights the importance of collaboration in scientific research.